These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21173177)

  • 1. Inhibitors of endoplasmic reticulum alpha-glucosidases potently suppress hepatitis C virus virion assembly and release.
    Qu X; Pan X; Weidner J; Yu W; Alonzi D; Xu X; Butters T; Block T; Guo JT; Chang J
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1036-44. PubMed ID: 21173177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions.
    Chang J; Block TM; Guo JT
    Antiviral Res; 2013 Sep; 99(3):251-60. PubMed ID: 23816430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors.
    Chapel C; Garcia C; Bartosch B; Roingeard P; Zitzmann N; Cosset FL; Dubuisson J; Dwek RA; Trépo C; Zoulim F; Durantel D
    J Gen Virol; 2007 Apr; 88(Pt 4):1133-1143. PubMed ID: 17374756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles.
    Chapel C; Garcia C; Roingeard P; Zitzmann N; Dubuisson J; Dwek RA; Trépo C; Zoulim F; Durantel D
    J Gen Virol; 2006 Apr; 87(Pt 4):861-871. PubMed ID: 16528036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel imino sugar α-glucosidase inhibitors as antiviral compounds.
    Howe JD; Smith N; Lee MJ; Ardes-Guisot N; Vauzeilles B; Désiré J; Baron A; Blériot Y; Sollogoub M; Alonzi DS; Butters TD
    Bioorg Med Chem; 2013 Aug; 21(16):4831-8. PubMed ID: 23582447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses.
    Chang J; Warren TK; Zhao X; Gill T; Guo F; Wang L; Comunale MA; Du Y; Alonzi DS; Yu W; Ye H; Liu F; Guo JT; Mehta A; Cuconati A; Butters TD; Bavari S; Xu X; Block TM
    Antiviral Res; 2013 Jun; 98(3):432-40. PubMed ID: 23578725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of host ER glucosidase activity prevents Golgi processing of virion-associated bovine viral diarrhea virus E2 glycoproteins and reduces infectivity of secreted virions.
    Jordan R; Nikolaeva OV; Wang L; Conyers B; Mehta A; Dwek RA; Block TM
    Virology; 2002 Mar; 295(1):10-9. PubMed ID: 12033761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents.
    Zitzmann N; Mehta AS; Carrouée S; Butters TD; Platt FM; McCauley J; Blumberg BS; Dwek RA; Block TM
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11878-82. PubMed ID: 10518544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avasimibe: A novel hepatitis C virus inhibitor that targets the assembly of infectious viral particles.
    Hu L; Li J; Cai H; Yao W; Xiao J; Li YP; Qiu X; Xia H; Peng T
    Antiviral Res; 2017 Dec; 148():5-14. PubMed ID: 29074218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes.
    Sayce AC; Alonzi DS; Killingbeck SS; Tyrrell BE; Hill ML; Caputo AT; Iwaki R; Kinami K; Ide D; Kiappes JL; Beatty PR; Kato A; Harris E; Dwek RA; Miller JL; Zitzmann N
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004524. PubMed ID: 26974655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus.
    Steinmann E; Whitfield T; Kallis S; Dwek RA; Zitzmann N; Pietschmann T; Bartenschlager R
    Hepatology; 2007 Aug; 46(2):330-8. PubMed ID: 17599777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualizing the Essential Role of Complete Virion Assembly Machinery in Efficient Hepatitis C Virus Cell-to-Cell Transmission by a Viral Infection-Activated Split-Intein-Mediated Reporter System.
    Zhao F; Zhao T; Deng L; Lv D; Zhang X; Pan X; Xu J; Long G
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27852847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: implications for the treatment of hepatitis C.
    Whitby K; Taylor D; Patel D; Ahmed P; Tyms AS
    Antivir Chem Chemother; 2004 May; 15(3):141-51. PubMed ID: 15266896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Affect of deoxynojirimycin derivatives on hepatitis C virus morphogenesis].
    Timokhova AV; Bakinovskiĭ LV; Zinin AI; Popenko VI; Ivanov AV; Rubtsov PM; Kochetkov SN; Belzhelarskaia SN
    Mol Biol (Mosk); 2012; 46(4):644-53. PubMed ID: 23113354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo.
    Chang J; Schul W; Butters TD; Yip A; Liu B; Goh A; Lakshminarayana SB; Alonzi D; Reinkensmeier G; Pan X; Qu X; Weidner JM; Wang L; Yu W; Borune N; Kinch MA; Rayahin JE; Moriarty R; Xu X; Shi PY; Guo JT; Block TM
    Antiviral Res; 2011 Jan; 89(1):26-34. PubMed ID: 21073903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins enhance extracellular release of hepatitis C virus particles through ERK5 activation.
    Aoki-Utsubo C; Kameoka M; Deng L; Hanafi M; Dewi BE; Sudarmono P; Wakita T; Hotta H
    Microbiol Immunol; 2024 Oct; 68(10):359-370. PubMed ID: 39073705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuralized E3 Ubiquitin Protein Ligase 3 Is an Inducible Antiviral Effector That Inhibits Hepatitis C Virus Assembly by Targeting Viral E1 Glycoprotein.
    Zhao Y; Cao X; Guo M; Wang X; Yu T; Ye L; Han L; Hei L; Tao W; Tong Y; Xu Y; Zhong J
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum.
    Courageot MP; Frenkiel MP; Dos Santos CD; Deubel V; Desprès P
    J Virol; 2000 Jan; 74(1):564-72. PubMed ID: 10590151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity.
    Karade SS; Hill ML; Kiappes JL; Manne R; Aakula B; Zitzmann N; Warfield KL; Treston AM; Mariuzza RA
    J Med Chem; 2021 Dec; 64(24):18010-18024. PubMed ID: 34870992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus.
    Miller JL; Tyrrell BE; Zitzmann N
    Adv Exp Med Biol; 2018; 1062():277-301. PubMed ID: 29845540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.